250 related articles for article (PubMed ID: 8510622)
1. Nursing care of the neonate receiving prostaglandin E1 therapy.
Rikard DH
Neonatal Netw; 1993 Jun; 12(4):17-22. PubMed ID: 8510622
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E1 treatment in patent ductus arteriosus dependent congenital heart defects.
Tálosi G; Katona M; Rácz K; Kertész E; Onozó B; Túri S
J Perinat Med; 2004; 32(4):368-74. PubMed ID: 15346826
[TBL] [Abstract][Full Text] [Related]
3. [Value of prostaglandin E1 in cardiac malformations in the newborn infant].
Sassolas F; Bozio A; Andre M; Jocteur-Monrozier D; Champsaur G; Normand J
Pediatrie; 1984 Jun; 39(4):245-52. PubMed ID: 6504667
[TBL] [Abstract][Full Text] [Related]
4. [Use of prostaglandins in neonatal cardiology].
Dinarević S; Kurtagić S; Maksić H
Med Arh; 2000; 54(5-6):279-82. PubMed ID: 11219904
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E1 in infants with congenital heart disease: Indian experience.
Saxena A; Sharma M; Kothari SS; Juneja R; Reddy SC; Sharma R; Bhan A; Venugopal P
Indian Pediatr; 1998 Nov; 35(11):1063-9. PubMed ID: 10216540
[TBL] [Abstract][Full Text] [Related]
6. Combined prostaglandin therapy and ductal formalin infiltration in neonatal pulmonary oligemia.
Larson JE; Fleming WH; Sarafian LB; Rogler WC; Hofschire PJ; McManus BM
J Thorac Cardiovasc Surg; 1985 Dec; 90(6):907-11. PubMed ID: 4068741
[TBL] [Abstract][Full Text] [Related]
7. Strategies for prolonged survival before heart transplantation in the neonatal intensive care unit.
Emery JR
J Heart Lung Transplant; 1993; 12(6 Pt 2):S161-3. PubMed ID: 8312329
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E1 treatment in ductus dependent congenital cardiac malformation. A review of the treatment of 34 neonates.
Høst A; Halken S; Kamper J; Lillquist K
Dan Med Bull; 1988 Feb; 35(1):81-4. PubMed ID: 3342648
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandins and the management of congenital heart disease.
Taylor WJ; Alpert BS
Am Fam Physician; 1982 Dec; 26(6):127-32. PubMed ID: 6890758
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E1: first stage palliation in neonates with congenital cardiac defects.
Reddy SC; Saxena A
Indian J Pediatr; 1998; 65(2):211-6. PubMed ID: 10771966
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E1 treatment of congenital heart disease: use prior to neonatal transport.
Buck ML
DICP; 1991 Apr; 25(4):408-9. PubMed ID: 1926911
[TBL] [Abstract][Full Text] [Related]
12. Gastric-outlet obstruction induced by prostaglandin therapy in neonates.
Peled N; Dagan O; Babyn P; Silver MM; Barker G; Hellmann J; Scolnik D; Koren G
N Engl J Med; 1992 Aug; 327(8):505-10. PubMed ID: 1635565
[TBL] [Abstract][Full Text] [Related]
13. Supportive and emergency use of prostaglandin in the neonate with congenital heart disease.
Hussain A; al Khudhairi D
Middle East J Anaesthesiol; 1993 Feb; 12(1):73-81. PubMed ID: 8316154
[TBL] [Abstract][Full Text] [Related]
14. Reappraisal of the prostaglandin E1 dose for early newborns with patent ductus arteriosus-dependent pulmonary circulation.
Huang FK; Lin CC; Huang TC; Weng KP; Liu PY; Chen YY; Wang HP; Ger LP; Hsieh KS
Pediatr Neonatol; 2013 Apr; 54(2):102-6. PubMed ID: 23590954
[TBL] [Abstract][Full Text] [Related]
15. Modified Blalock-Taussig shunt following long-term administration of prostaglandin E1 for ductus-dependent neonates with cyanotic congenital heart disease.
Yokota M; Muraoka R; Aoshima M; Nomoto S; Shiraishi Y; Kyoku I; Kitano M; Shimada I; Nakano H; Ueda K
J Thorac Cardiovasc Surg; 1985 Sep; 90(3):399-403. PubMed ID: 4033176
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E1 for maintaining ductal patency in neonates with ductal-dependent cardiac lesions.
Akkinapally S; Hundalani SG; Kulkarni M; Fernandes CJ; Cabrera AG; Shivanna B; Pammi M
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011417. PubMed ID: 29486048
[TBL] [Abstract][Full Text] [Related]
17. [Neonatal cortical hyperostosis. A side effect of prolonged prostaglandin E1 infusion].
Fernández MA; Gebara E
Arch Argent Pediatr; 2011 Apr; 109(2):154-9. PubMed ID: 21465075
[TBL] [Abstract][Full Text] [Related]
18. [Infusion of prostaglandin E1 in ductus-dependent congenital heart diseases. Analysis of 47 cases].
Atik E; Gutiérrez JA; Lyra Filho FJ; Iwahashi ER; Ribeiro IG; De Albuquerque AM; Barbero-Marcial M; Ebaid M
Arq Bras Cardiol; 1989 Aug; 53(2):93-7. PubMed ID: 2624556
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of alprostadil (prostaglandin E1) in the management of congenital heart disease in infancy.
Heymann MA; Clyman RI
Pharmacotherapy; 1982; 2(3):148-55. PubMed ID: 6763200
[TBL] [Abstract][Full Text] [Related]
20. [Prostaglandin E1 therapy in infants with cyanotic congenital heart malformations: hemodynamic and angiographic findings (author's transl)].
Schumacher G; Mocellin R; Schöber JG; Kellner M; Bühlmeyer K
Klin Padiatr; 1978 Sep; 190(5):465-73. PubMed ID: 568198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
